1 Min Read
Dec 21 (Reuters) - Intellipharmaceutics International Inc
* Intellipharmaceutics announces issuance of U.S. and Canadian patents covering aspects of its Podras overdose technology Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.